Indian Dermatology Online Journal

: 2014  |  Volume : 5  |  Issue : 4  |  Page : 426--435

Melasma update

Rashmi Sarkar1, Pooja Arora2, Vijay Kumar Garg1, Sidharth Sonthalia3, Narendra Gokhale4 
1 Department of Dermatology, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India
2 Department of Dermatology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India
3 Skin Clinic, Skinnocence, Sushant Lok, Gurgaon, Haryana, India
4 Skin Clinic, Sklinic, Indore, Madhya Pradesh, India

Correspondence Address:
Pooja Arora
9541, Sector C, Pocket 9, Vasant Kunj, New Delhi - 110 070

Melasma is an acquired pigmentary disorder characterized by symmetrical hyperpigmented macules on the face. Its pathogenesis is complex and involves the interplay of various factors such as genetic predisposition, ultraviolet radiation, hormonal factors, and drugs. An insight into the pathogenesis is important to devise treatment modalities that accurately target the disease process and prevent relapses. Hydroquinone remains the gold standard of treatment though many newer drugs, especially plant extracts, have been developed in the last few years. In this article, we review the pathogenetic factors involved in melasma. We also describe the newer treatment options available and their efficacy. We carried out a PubMed search using the following terms «DQ»melasma, pathogenesis, etiology, diagnosis, treatment«DQ» and have included data of the last few years.

How to cite this article:
Sarkar R, Arora P, Garg VK, Sonthalia S, Gokhale N. Melasma update .Indian Dermatol Online J 2014;5:426-435

How to cite this URL:
Sarkar R, Arora P, Garg VK, Sonthalia S, Gokhale N. Melasma update . Indian Dermatol Online J [serial online] 2014 [cited 2021 Jul 28 ];5:426-435
Available from:;year=2014;volume=5;issue=4;spage=426;epage=435;aulast=Sarkar;type=0